MOTS-c vs SS-31 mitochondrial peptides serve distinct roles in cellular energy research: one builds new mitochondria, the other repairs existing ones. Here is the clinical breakdown.
MOTS-c vs SS-31 mitochondrial peptides represent two of the most studied compounds in cellular energy research today. Both target mitochondrial function. Both have shown measurable effects in animal models and cellular studies. But they operate through completely different mechanisms — and choosing the right one for a given research protocol depends on understanding precisely what each does at the organelle level.
The short version: SS-31 protects and repairs mitochondria that already exist. MOTS-c signals the cell to build new ones. Both outcomes matter in aging and metabolic research, but they answer different experimental questions.
Mitochondrial dysfunction is one of the most consistent findings in aging biology. As cells age, mitochondria accumulate damage — membrane integrity deteriorates, electron transport chain efficiency drops, and reactive oxygen species production increases. The result is a progressive decline in cellular ATP output that underlies many physiological changes.
Two distinct problems emerge. First, existing mitochondria become damaged and inefficient. Second, the cell’s capacity to generate new mitochondria — a process called mitochondrial biogenesis — declines. These are separate problems requiring separate interventions, which is why MOTS-c and SS-31 are researched as complementary compounds.
SS-31 (Elamipretide) is a tetrapeptide that specifically targets cardiolipin — a phospholipid found almost exclusively in the inner mitochondrial membrane. Cardiolipin maintains the cristae architecture and is essential for electron transport chain function. In oxidative stress models, cardiolipin oxidizes, destabilizing the entire energy production chain.
SS-31 binds directly to cardiolipin, stabilizes the inner membrane, and restores electron transport chain efficiency in damaged mitochondria. Research published in Cell Metabolism demonstrated that SS-31 could reverse age-related skeletal muscle mitochondrial dysfunction in animal models, restoring exercise capacity.
MOTS-c is encoded within mitochondrial DNA and functions primarily as a regulator of AMPK, driving mitochondrial biogenesis through the PGC-1α pathway. While SS-31 repairs existing organelles, MOTS-c increases the number of mitochondria per cell and enhances overall oxidative capacity.
Here is how to think about the research choice. If your model features acute mitochondrial damage (oxidative stress, ischemia), SS-31 is the targeted intervention. If your model is studying chronic metabolic decline or conditions where cellular energy capacity needs to be rebuilt, MOTS-c is the appropriate tool.
Beyond Health Lab supplies MOTS-c 10mg and SS-31 50mg at ≥99% verified purity, with third-party HPLC testing and a Certificate of Analysis on every lot. Both ship lyophilized for stability and arrive ready for reconstitution with bacteriostatic water.
Join 10,000+ researchers. Get your discount code, early access to new compounds, and protocol insights.
No spam, ever. Unsubscribe anytime.
Check your inbox for your discount code.
Here's a preview:
Valid on all products · Single use
